We found that in vivo neutralization of IL-6 conferred a survival benefit and was associated with a reduced bacterial burden in the lung and pro-inflammatory cytokine expression in Mtb-infected mice with acute or chronic T2DM; however, it did not alter the hyperglycemic status of the mice. The gene discussed is IL6; the disease is type 2 diabetes mellitus.